Levetiracetam monotherapy for the treatment of infants with epilepsy
Keywords: لوتیراستام; Epilepsy; Infant; Levetiracetam; Seizures;
مقالات ISI لوتیراستام (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Association between stroke-like episodes and neuronal hyperexcitability in MELAS with m.3243A>G: A case report
Keywords: لوتیراستام; MELAS; Stroke-like episodes; Hyperexcitability; Levetiracetam;
Effects of Levetiracetam and Sulthiame on EEG in benign epilepsy with centrotemporal spikes: A randomized controlled trial
Keywords: لوتیراستام; EEG; Anticonvulsive treatment; BECTS; Pediatric epilepsy; Sulthiame; Levetiracetam;
Biocatalytic production of (S)-2-aminobutanamide by a novel d-aminopeptidase from Brucella sp. with high activity and enantioselectivity
Keywords: لوتیراستام; d-Aminopeptidase; Kinetic resolution; (S)-2-aminobutanamide; Levetiracetam;
Preparation of 99mTc-levetiracetam intranasal microemulsion as the first radiotracer for SPECT imaging of the Synaptic Vesicle Protein SV2A
Keywords: لوتیراستام; Radiopharmaceuticals; Receptor imaging; Levetiracetam; Microemulsion;
Tolerability of adjunctive eslicarbazepine acetate according to concomitant lamotrigine or carbamazepine use: A subgroup analysis of three phase III trials in adults with focal (partial-onset) seizures
Keywords: لوتیراستام; AE; adverse event; AED; antiepileptic drug; CBZ; carbamazepine; +CBZ; patients who were taking concomitant CBZ; -CBZ; patients who were not taking concomitant CBZ; ESL; eslicarbazepine acetate; FS; focal seizures; LEV; levetiracetam; LCM; lacosamide; LT
The anti-epileptic drugs valproate, carbamazepine and levetiracetam cause bone loss and modulate Wnt inhibitors in normal and ovariectomised rats
Keywords: لوتیراستام; AEDs; antiepileptic drugs; CBZ; carbamazepine; SVP; sodium valproate; LTM; levetiracetam; RANKL; receptor activator of nuclear factor kappa β-ligand; P1NP; procollagen type 1 amino-terminal propeptide; BMD; bone mineral density; DKK-1; Dickkopf 1; CPCSEA
Determination of plasma Levetiracetam level by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS-MS) and its application in pharmacokinetics studies in neonates
Keywords: لوتیراستام; Liquid chromatography; Tandem mass spectrometry; Levetiracetam; Pharmacokinetics; Neonates;
The novel, catalytic mTORC1/2 inhibitor PQR620 and the PI3K/mTORC1/2 inhibitor PQR530 effectively cross the blood-brain barrier and increase seizure threshold in a mouse model of chronic epilepsy
Keywords: لوتیراستام; Epilepsy; Rapamycin; Everolimus; Pharmacokinetics; Tolerability; Levetiracetam; AKT; protein kinase B; ASD; anti-seizure drug; 4E-BP1; initiation factor 4E binding protein; HPβCD; hydroxypropyl-Ã-cyclodextrin; MTD; maximal tolerated dose; MES-T; maximal
Acute liver injury induced by levetiracetam and temozolomide co-treatment
Keywords: لوتیراستام; Drug induced liver injury; Levetiracetam; Temozolomide;
Case ReportMarked EEG worsening following Levetiracetam overdose: How a pharmacological issue can confound coma prognosis
Keywords: لوتیراستام; Levetiracetam; Burst suppression; Post anoxic coma; Overdose; Awakening prognosis;
Original ArticleSeizures and Antiseizure Medications are Important to Parents of Newborns With Seizures
Keywords: لوتیراستام; neonatal seizures; survey; phenobarbital; levetiracetam; patient-centered outcomes; parent; epilepsy; antiseizure medication;
Impact of seizure frequency reduction on health-related quality of life among clinical trial subjects with refractory partial-onset seizures: A pooled analysis of phase III clinical trials of eslicarbazepine acetate
Keywords: لوتیراستام; ANCOVA; analysis of covariance; AED; antiepileptic drug; CF; cognitive functioning; EWB; emotional well-being; EF; energy/fatigue; ESL; eslicarbazepine acetate; HRQOL; health-related quality of life; LEV; levetiracetam; LSM; least square mean; ME; medicat
Population pharmacokinetics and dose-response relationship of levetiracetam in adult patients with epilepsy
Keywords: لوتیراستام; Levetiracetam; Population pharmacokinetics; Non-linear mixed effect model; Seizure control; Dose titration;
Efficacy of anticonvulsant substances in the 6Â Hz seizure test: Comparison of two rodent species
Keywords: لوتیراستام; ADD; anticonvulsant drug development; AED; antiepileptic drug; g; grams; Hz; hertz; i.p.; intraperitoneal; LEV; levetiracetam; LTG; lamotrigine; MES; maximal electroconvulsive shock; NMRI; national marine research institute; PD; pharmacodynamics; PHT; phe
Levetiracetam + nonsteroidal anti-inflammatory drug binary systems: A contribution to the development of new solid dosage forms
Keywords: لوتیراستام; Levetiracetam; NSAID; Eutectics; Co-crystals; Chiral discrimination; Dissolution rate;
Intravenous levetiracetam vs phenytoin for status epilepticus and cluster seizures: A prospective, randomized study
Keywords: لوتیراستام; Status Epilepticus; Cluster Seizures; Levetiracetam; Phenytoin; Anticonvulsant treatment;
Conformational Preference and Spectroscopical Characteristics of the Active Pharmaceutical Ingredient Levetiracetam
Keywords: لوتیراستام; levetiracetam; conformational analysis; hydrogen-bonded dimers; NMR; UV-Vis; DFT;
Changes in hormone and lipid levels in male patients with focal seizures when switched from carbamazepine to lacosamide as adjunctive treatment to levetiracetam: A small phase IIIb, prospective, multicenter, open-label trial
Keywords: لوتیراستام; AE; adverse event; AED; antiepileptic drug; CBZ; carbamazepine; C-SSRS; Columbia Suicide Severity Rating Scale; CYP450; cytochrome P450; fT4; free thyroxine; HDL; high-density lipoprotein; LDL; low-density lipoprotein; LEV; levetiracetam; SHBG; sex-hormon
Levetiracetam attenuates rotenone-induced toxicity: A rat model of Parkinson's disease
Keywords: لوتیراستام; Levetiracetam; Rotenone; Parkinson's disease; Oxidative stress;
ReviewDirect and indirect comparison meta-analysis of levetiracetam versus phenytoin or valproate for convulsive status epilepticus
Keywords: لوتیراستام; Clinical trials randomized controlled; Levetiracetam; Meta-analysis; Phenytoin; Status epilepticus; Valproate;
Levetiracetam extended release for the treatment of patients with partial-onset seizures: A long-term, open-label follow-up study
Keywords: لوتیراستام; Levetiracetam; Extended release; Antiepileptic drug; Partial-onset seizures; Monotherapy; Long-termAED, antiepileptic drug; DB, double-blind; ECg, electrocardiogram; IR, immediate release; ITT, intent-to-treat; LEV, levetiracetam; OL, open-label; POS, par
Anticonvulsant Efficacy in Sturge-Weber Syndrome
Keywords: لوتیراستام; anticonvulsant; Sturge-Weber syndrome; epilepsy; side effects; carbamazepine; oxcarbazepine; levetiracetam
Pharmaco fMRI: Determining the functional anatomy of the effects of medication
Keywords: لوتیراستام; ACC; anterior cingulate cortex; AED; antiepileptic drugs; ADHD; attention-deficit/hyperactivity disorder; BOLD; blood oxygen level-dependent signal; CBZ; carbamazepine; CNS; central nervous system; DAT; dopamine transporter; JME; juvenile myoclonic epilep
Physiochemical characterization of taste masking levetiracetam ion exchange resinates in the solid state and formulation of stable liquid suspension for pediatric use
Keywords: لوتیراستام; Levetiracetam; Taste masking; Ion-exchange resins; Solid-state characteristics; Suspension
Original ArticleSafety of levetiracetam among infants younger than 12 months - Results from a European multicenter observational study
Keywords: لوتیراستام; Levetiracetam; Safety; Infants; Epilepsy; Children;
Levetiracetam treatment influences blood-brain barrier failure associated with angiogenesis and inflammatory responses in the acute phase of epileptogenesis in post-status epilepticus mice
Keywords: لوتیراستام; Levetiracetam; Blood-brain barrier; Epileptogenesis; Microglia; Angiogenesis; Status epilepticus
Brief CommunicationAn open-label, prospective, exploratory study of patients with epilepsy switching from levetiracetam to brivaracetam
Keywords: لوتیراستام; Behavioral adverse event; Brivaracetam; Epilepsy; Quality of life; Levetiracetam;
Levetiracetam versus phenytoin in management of status epilepticus
Keywords: لوتیراستام; Levetiracetam; Phenytoin; Randomized trial; Seizures; Status epilepticus
Intravenous levetiracetam in clinical practice – Results from an independent registry
Keywords: لوتیراستام; Levetiracetam; Intravenous; Status epilepticus; Efficacy; Tolerability; Practicability
The efficacy of levetiracetam for patients with supratentorial brain tumors
Keywords: لوتیراستام; Efficacy; Levetiracetam; Meta-analysis; Supratentorial brain tumors
Seletracetam enhances short term depression in vitro
Keywords: لوتیراستام; ACSF; artificial cerebrospinal fluid; CNQX; 6-cyano-7-nitroquinoxaline-2,3-dione; fEPSP; field excitatory postsynaptic potential; LEV; levetiracetam; SEL; seletracetam; STD; short term depression; SV2A; synaptic vesicle protein 2A; Antiepileptic drugs; An
Intravenous levetiracetam in Thai children and adolescents with status epilepticus and acute repetitive seizures
Keywords: لوتیراستام; Levetiracetam; Status epilepticus; Acute repetitive seizures; Childhood seizures;
Validation of the 6 Hz refractory seizure mouse model for intracerebroventricularly administered compounds
Keywords: لوتیراستام; AEDs; anti-epileptic drugs; BBB; blood-brain barrier; CA; Cornu Ammonis; CC; critical current; DG; dentate gyrus; Hz; Hertz; i.c.v.; intracerebroventricular(ly); i.p.; intraperitoneal(ly); LEV; levetiracetam; PBS; phosphate buffered saline; PHT; sodium
Homozygous Mutation in Synaptic Vesicle Glycoprotein 2A Gene Results in Intractable Epilepsy, Involuntary Movements, Microcephaly, and Developmental and Growth Retardation
Keywords: لوتیراستام; SV2a; epilepsy; exome; levetiracetam;
Episodic tremors representing cortical myoclonus are characteristic in Angelman syndrome due to UBE3A mutations
Keywords: لوتیراستام; Jerk-locked averaging; Levetiracetam; Myoclonic absence; Tremor; UBE3A mutations
The antiepileptic drug lamotrigine is a substrate of mouse and human breast cancer resistance protein (ABCG2)
Keywords: لوتیراستام; Epilepsy; Pharmacoresistance; Transporter hypothesis; P-glycoprotein; AED; antiepileptic drug; AUC; area under curve; BBB; blood-brain barrier; BCRP/Bcrp; breast cancer resistance protein; CETA; concentration equilibrium transport assay; MDCK; Madin-Dar
Development and validation of a GC/MS method for the simultaneous determination of levetiracetam and lamotrigine in whole blood
Keywords: لوتیراستام; Levetiracetam; Lamotrigine; Antiepileptics; Blood; GC/MS;
Levetiracetam synergises with common analgesics in producing antinociception in a mouse model of painful diabetic neuropathy
Keywords: لوتیراستام; Levetiracetam; Ibuprofen; Aspirin; Paracetamol; Synergism; Diabetic neuropathy; Levetiracetam (PubChem CID: 5284583); Ibuprofen (PubChem CID: 3672); Acetylsalicylic acid (PubChem CID: 2244); Paracetamol (PubChem CID: 1983); Streptozotocin (PubChem CID: 29
Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Levetiracetam
Keywords: لوتیراستام; absorption; bioavailability; bioequivalence; biopharmaceutical classification system (BCS); biowaiver; levetiracetam; pharmacokinetics; permeability; solubility
Management of generalised convulsive status epilepticus (SE): A prospective randomised controlled study of combined treatment with intravenous lorazepam with either phenytoin, sodium valproate or levetiracetam - Pilot study
Keywords: لوتیراستام; Efficacy of AEDs; GCSE; Levetiracetam; Phenytoin; Status epilepticus; Valproate;
Levetiracetam as a Possible Contributor to Acute Kidney Injury
Keywords: لوتیراستام; epilepsy; levetiracetam; medication toxicity; renal failure, seizures;
Levetiracetam in the treatment of pediatric headache
Keywords: لوتیراستام; Dysrhthmias; Headache; Levetiracetam; Pediatric
Adjunctive Levetiracetam Treatment in Pediatric Lennox-Gastaut Syndrome
Keywords: لوتیراستام; levetiracetam; Lennox-Gastaut syndrome; child; efficacy; tolerability
ReviewThe fetal safety of Levetiracetam: A systematic review
Keywords: لوتیراستام; AEDs; antiepileptic drugs; GMDS; Griffiths Mental Development Scale; LEV; Levetiracetam; LTG; lamotrigine; MCM; major congenital malformation; NAARP; North American Pregnancy Antiepilepsy Registry; TPM; topiramate; VPA; valproic acid; Pregnancy; Levetirac
Continuation rates of levetiracetam in children from the EULEVp cohort study
Keywords: لوتیراستام; Pediatrics; Antiepileptic drugs; Cohort studies; Epilepsy; Levetiracetam; Effectiveness
Evaluation of levetiracetam and valproic acid as low-dose monotherapies for children with typical benign childhood epilepsy with centrotemporal spikes (BECTS)
Keywords: لوتیراستام; Benign childhood epilepsy with centrotemporal spikes; Levetiracetam; Valproic acid; Low dosage; Monotherapy;
Measurement of levetiracetam drug levels to assist with seizure control and monitoring of drug interactions with other anti-epileptic medications (AEMs)
Keywords: لوتیراستام; Levetiracetam; Epilepsy; Drug interaction; Therapeutic monitoring
Valproic acid, but not levetiracetam, selectively decreases HDAC7 and HDAC2 expression in human ovarian cancer cells
Keywords: لوتیراستام; Valproic acid; Levetiracetam; Histone deacetylases; Ovarian cancer cell line OVCAR-3;
Efficacy and Safety of IV Levetiracetam in Children With Acute Repetitive Seizures
Keywords: لوتیراستام; levetiracetam; acute repetitive seizures; children; antiepileptic drugs